IM Cannabis (IMCC) Retained Earnings (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Retained Earnings of -$198.6 million for Q1 2026, down 10.2% year-over-year from -$221.2 million in Q1 2025, and down 2.51% quarter-over-quarter from -$193.8 million in Q4 2025.
IM Cannabis (IMCC) Retained Earnings (2019 - 2026) Analysis & Trends
IM Cannabis' Retained Earnings history runs 8 years deep, the most recent figure standing at -$198.6 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 10.2% year-over-year to -$198.6 million; the TTM figure through Mar 2026 stood at -$198.6 million (down 10.2% YoY), while the FY2025 annual figure was -$193.8 million, down 2.45% from the prior year.
- Retained Earnings for Q1 2026 stood at -$198.6 million, down from -$193.8 million in the prior quarter.
- The five-year high for Retained Earnings was -$47.5 million in Q1 2022, with the low at -$198.6 million in Q1 2026.
- The 5-year median for Retained Earnings is -$183.3 million (2023), against an average of -$169.0 million.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 338.43% in 2022, then climbed 4.91% in 2025.
- IM Cannabis' Retained Earnings stood at -$176.5 million in 2022, then declined by 3.69% to -$183.0 million in 2023, then decreased by 1.29% to -$185.4 million in 2024, then decreased by 4.53% to -$193.8 million in 2025, then slipped by 2.51% to -$198.6 million in 2026.
- Business Quant data shows IMCC's Retained Earnings at -$198.6 million in Q1 2026, -$193.8 million in Q4 2025, and -$190.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -200.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -200.06 Mn |
| Mar 31, 2026 | -198.62 Mn |
| Dec 31, 2025 | -193.76 Mn |
| Sep 30, 2025 | -190.80 Mn |
| Jun 30, 2025 | -186.87 Mn |
| Mar 31, 2025 | -180.24 Mn |
| Dec 31, 2024 | -185.36 Mn |
| Sep 30, 2024 | -190.15 Mn |
| Jun 30, 2024 | -188.98 Mn |
| Mar 31, 2024 | -189.56 Mn |
| Dec 31, 2023 | -183.01 Mn |
| Sep 30, 2023 | -183.31 Mn |
| Jun 30, 2023 | -181.35 Mn |
| Mar 31, 2023 | -176.96 Mn |
| Dec 31, 2022 | -176.49 Mn |
| Sep 30, 2022 | -158.41 Mn |
| Jun 30, 2022 | -61.85 Mn |
| Mar 31, 2022 | -47.52 Mn |
| Dec 31, 2021 | -40.26 Mn |
| Dec 31, 2020 | -25.31 Mn |